In the increases in increases in the possibility of enhanced insulin sensitivity, as was also shown in a study investigating the effect of FK614 and pioglitazone, a thiazolidinedione PPARγ agonist in the Zucker fatty rat, an animal model for diabetes [54]. This evidence concerns the gene PPARG and diabetes mellitus.